FFCP PHASE1:Mm9::chr3:68958945..68958954,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=6|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr3:68958945..68958954,+|id=chr3:68958945..68958954,+|ontology_enrichment_celltype=CL:0000553!8.35e-10!6;CL:0000556!8.35e-10!6;CL:0002031!1.36e-08!25;CL:0000815!1.33e-07!1;CL:0000792!1.33e-07!1;CL:0000945!2.05e-07!1;CL:0000236!2.05e-07!1;CL:0000826!2.05e-07!1|ontology_enrichment_celltype_v019_2=CL:0000355,1.26e-10,9|ontology_enrichment_disease=DOID:0060100!9.97e-10!3;DOID:4045!9.97e-10!3|ontology_enrichment_disease_v019_2=DOID:0060100,1.54e-29,3;DOID:4045,1.54e-29,3;DOID:0050686,2.21e-15,6|ontology_enrichment_uberon=UBERON:0000996!9.86e-08!1|ontology_enrichment_uberon_v019_2=UBERON:0001134,1.26e-10,9;UBERON:0002036,1.26e-10,9;UBERON:0002385,1.26e-10,9;UBERON:0000486,1.26e-10,9;UBERON:0007503,1.26e-10,9;UBERON:0001015,1.26e-10,9;UBERON:0002329,1.26e-10,9;UBERON:0003082,1.26e-10,9;UBERON:0003059,1.26e-10,9;UBERON:0007282,1.26e-10,9;UBERON:0004290,1.26e-10,9;UBERON:0009618,1.26e-10,9;UBERON:0000383,1.14e-09,10;UBERON:0007524,6.95e-09,11;UBERON:0003077,6.95e-09,11;UBERON:0007285,6.95e-09,11|phase1_expression=0,0,0,0,0,0,0,0.258246646883153,0,0,0,0,0,0.174840804837995,0,0,0,0.157731082679119,0.137114433605739,0.42438965179803,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.25559489221072,1.5626706890476,0,24.1174910092716,8.19654581950135,0.485510353031154,0,0,0,0,0,0,0,0,0,0.167782606057736,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.11418387971906,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.184753190166605,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.428736758158132,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr3:68958945..68958954,+}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=6 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr3:68958945..68958954,+ | |||
|description=CAGE_peak_at_chr3:68958945..68958954,+ | |||
|id=chr3:68958945..68958954,+ | |||
|ontology_enrichment_celltype=CL:0000553!8.35e-10!6;CL:0000556!8.35e-10!6;CL:0002031!1.36e-08!25;CL:0000815!1.33e-07!1;CL:0000792!1.33e-07!1;CL:0000945!2.05e-07!1;CL:0000236!2.05e-07!1;CL:0000826!2.05e-07!1 | |||
|ontology_enrichment_celltype_v019_2=CL:0000355,1.26e-10,9 | |||
|ontology_enrichment_disease=DOID:0060100!9.97e-10!3;DOID:4045!9.97e-10!3 | |||
|ontology_enrichment_disease_v019_2=DOID:0060100,1.54e-29,3;DOID:4045,1.54e-29,3;DOID:0050686,2.21e-15,6 | |||
|ontology_enrichment_uberon=UBERON:0000996!9.86e-08!1 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0001134,1.26e-10,9;UBERON:0002036,1.26e-10,9;UBERON:0002385,1.26e-10,9;UBERON:0000486,1.26e-10,9;UBERON:0007503,1.26e-10,9;UBERON:0001015,1.26e-10,9;UBERON:0002329,1.26e-10,9;UBERON:0003082,1.26e-10,9;UBERON:0003059,1.26e-10,9;UBERON:0007282,1.26e-10,9;UBERON:0004290,1.26e-10,9;UBERON:0009618,1.26e-10,9;UBERON:0000383,1.14e-09,10;UBERON:0007524,6.95e-09,11;UBERON:0003077,6.95e-09,11;UBERON:0007285,6.95e-09,11 | |||
|phase1_expression=0,0,0,0,0,0,0,0.258246646883153,0,0,0,0,0,0.174840804837995,0,0,0,0.157731082679119,0.137114433605739,0.42438965179803,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.25559489221072,1.5626706890476,0,24.1174910092716,8.19654581950135,0.485510353031154,0,0,0,0,0,0,0,0,0,0.167782606057736,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.11418387971906,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.184753190166605,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.428736758158132,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr3:68958945..68958954,+ | |||
}} |
Latest revision as of 23:52, 3 August 2015
Short description: | p@chr3:68958945..68958954, + |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr3:68958945..68958954, + |
Coexpression cluster: | MCL_coexpression_mm9:6 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
multi-potent skeletal muscle stem cell | 1.26e-10 | 9 |
Ontology term | p-value | n |
---|---|---|
skeletal muscle tissue | 1.26e-10 | 9 |
striated muscle tissue | 1.26e-10 | 9 |
muscle tissue | 1.26e-10 | 9 |
multilaminar epithelium | 1.26e-10 | 9 |
epithelial vesicle | 1.26e-10 | 9 |
musculature | 1.26e-10 | 9 |
somite | 1.26e-10 | 9 |
myotome | 1.26e-10 | 9 |
presomitic mesoderm | 1.26e-10 | 9 |
presumptive segmental plate | 1.26e-10 | 9 |
dermomyotome | 1.26e-10 | 9 |
trunk paraxial mesoderm | 1.26e-10 | 9 |
musculature of body | 1.14e-09 | 10 |
dense mesenchyme tissue | 6.95e-09 | 11 |
paraxial mesoderm | 6.95e-09 | 11 |
presumptive paraxial mesoderm | 6.95e-09 | 11 |
Ontology term | p-value | n |
---|---|---|
musculoskeletal system cancer | 1.54e-29 | 3 |
muscle cancer | 1.54e-29 | 3 |
organ system cancer | 2.21e-15 | 6 |